What is the recommended dose of ivermectin (antiparasitic medication) in tablets for adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ivermectin Tablet Dosing for Adults

The standard dose of ivermectin tablets for adults is 200 mcg/kg (0.2 mg/kg) as a single oral dose, taken on an empty stomach with water. 1, 2

Standard Dosing by Body Weight

For practical administration, the FDA-approved dosing guidelines provide the following tablet counts (using 3 mg tablets) 2:

  • 15-24 kg: 1 tablet (3 mg)
  • 25-35 kg: 2 tablets (6 mg)
  • 36-50 kg: 3 tablets (9 mg)
  • 51-65 kg: 4 tablets (12 mg)
  • 66-79 kg: 5 tablets (15 mg)
  • ≥80 kg: Calculate 200 mcg/kg

Administration Guidelines

Ivermectin must be taken on an empty stomach with water to optimize bioavailability. 1, 2 Taking the medication with food increases absorption and enhances drug penetration into the epidermis, which is beneficial for ectoparasitic infections like scabies. 1

Indication-Specific Dosing Variations

Strongyloidiasis (Intestinal Threadworm)

  • Standard regimen: 200 mcg/kg single dose 1, 2
  • Immunocompromised patients: 200 mcg/kg on days 1,2,15, and 16 1
  • Hyperinfection syndrome: Requires prolonged treatment with specialist consultation 1

Scabies

  • Standard regimen: 200 mcg/kg orally, repeated in 2 weeks 1
  • The second dose is necessary because ivermectin has limited ovicidal activity and may not prevent hatching of eggs present at initial treatment 1

Onchocerciasis (River Blindness)

  • Lower dose: 150 mcg/kg as a single dose 2
  • Retreatment intervals typically 12 months in mass campaigns, but can be as short as 3 months for individual patients 2

Loiasis (African Eye Worm)

  • Alternative dosing: 150-200 mcg/kg 1, 3
  • May be given as single dose or repeated at monthly, quarterly, or biannual intervals depending on microfilarial load 1
  • Critical caveat: Microfilarial threshold of <8000 mf/ml is generally recommended before ivermectin use to avoid severe adverse reactions 1

Important Clinical Considerations

Renal and Hepatic Impairment

No dose adjustments are required for renal impairment. 1 However, the safety of multiple doses in patients with severe liver disease is not established. 1

Pregnancy and Lactation

Ivermectin is classified as "human data suggest low risk" in pregnancy and is probably compatible with breastfeeding. 1 Permethrin is preferred as first-line for scabies in pregnant women when topical therapy is appropriate. 1

Pediatric Restrictions

Children under 10 years of age should not receive ivermectin for scabies. 1 Permethrin cream is the preferred treatment in this age group. 1

Critical Safety Warning

One study demonstrated increased mortality among elderly, debilitated persons who received ivermectin, though this has not been confirmed in subsequent reports. 1 Exercise caution when treating frail elderly patients and consider alternative therapies when appropriate.

Co-infection Screening

Always exclude co-existing onchocerciasis before treating loiasis, and exclude loiasis before treating lymphatic filariasis or onchocerciasis. 1 Co-infection can lead to severe Mazzotti reactions including encephalitis in hypermicrofilaremic patients. 1

Alternative Dosing in Literature

Some guidelines accept 150 mcg/kg as an alternative dose, particularly for onchocerciasis. 1, 3 However, the 200 mcg/kg dose is more widely recommended across multiple parasitic indications and represents the most current guideline consensus. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Hookworm Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.